Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses

Strategies to induce broadly protective antibody responses to viral glycoproteins

(2017) F Krammer   Expert Review of Vaccines

Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice

(2017) Nicholas J. Lennemann et al.   JOURNAL OF VIROLOGY

Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model

(2017) James Duehr et al.   JOURNAL OF VIROLOGY

Structural basis for antibody-mediated neutralization of Lassa virus

(2017) Kathryn M. Hastie et al.   SCIENCE

Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice

(2017) Wenqian He et al.   Nature Communications

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes

(2017) Teddy John Wohlbold et al.   Nature Microbiology

Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody

(2017) Veronika Chromikova et al.   PLoS One

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

(2016) Carole J. Henry Dunand et al.   Cell Host & Microbe

Novel drug discovery approaches for treating arenavirus infections

(2016) Antonella Pasquato et al.   Expert Opinion on Drug Discovery

Monoclonal antibody therapy for Junin virus infection

(2016) Larry Zeitlin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Serro 2 Virus Highlights the Fundamental Genomic and Biological Features of a Natural Vaccinia Virus Infecting Humans

(2016) Giliane Trindade et al.   Viruses-Basel

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

(2016) James E. Robinson et al.   Nature Communications

Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever

(2016) Lisa Oestereich et al.   PLoS Pathogens

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

(2016) Gene S. Tan et al.   PLoS Pathogens

Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice

(2015) Teddy John Wohlbold et al.   JOURNAL OF VIROLOGY

Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice

(2015) Teddy John Wohlbold et al.   mBio

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses

(2015) David Safronetz et al.   PLoS Neglected Tropical Diseases

Mucosal Polyinosinic-Polycytidylic Acid Improves Protection Elicited by Replicating Influenza Vaccines via Enhanced Dendritic Cell Function and T Cell Immunity

(2014) J. V. Perez-Giron et al.   JOURNAL OF IMMUNOLOGY

Characterization of a Broadly Neutralizing Monoclonal Antibody That Targets the Fusion Domain of Group 2 Influenza A Virus Hemagglutinin

(2014) G. S. Tan et al.   JOURNAL OF VIROLOGY

Epidemiology and pathogenesis of Bolivian hemorrhagic fever

(2014) Michael Patterson et al.   Current Opinion in Virology

Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever

(2014) Lisa Oestereich et al.   PLoS Neglected Tropical Diseases

Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System

(2013) Irina Margine et al.   Jove-Journal of Visualized Experiments

A Pan-H1 Anti-Hemagglutinin Monoclonal Antibody with Potent Broad-Spectrum Efficacy In Vivo

(2012) G. S. Tan et al.   JOURNAL OF VIROLOGY

A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin Substrates

(2012) Florian Krammer et al.   PLoS One

Highly Conserved Protective Epitopes on Influenza B Viruses

(2012) C. Dreyfus et al.   SCIENCE

Envelope Glycoprotein of Arenaviruses

(2012) Dominique J. Burri et al.   Viruses-Basel

Pathogenesis of Lassa Fever

(2012) Nadezhda E. Yun et al.   Viruses-Basel

Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242

(2011) Antonella Pasquato et al.   VIROLOGY

Rescue from Cloned cDNAs and In Vivo Characterization of Recombinant Pathogenic Romero and Live-Attenuated Candid #1 Strains of Junin Virus, the Causative Agent of Argentine Hemorrhagic Fever Disease

(2010) S. F. Emonet et al.   JOURNAL OF VIROLOGY

Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses

(2010) Jonathan Abraham et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins

(2010) Taia T. Wang et al.   PLoS Pathogens

Targeting the Proteolytic Processing of the Viral Glycoprotein Precursor Is a Promising Novel Antiviral Strategy against Arenaviruses

(2009) J. M. Rojek et al.   JOURNAL OF VIROLOGY

A Multivalent and Cross-Protective Vaccine Strategy against Arenaviruses Associated with Human Disease

(2009) Maya F. Kotturi et al.   PLoS Pathogens

Different Mechanisms of Cell Entry by Human-Pathogenic Old World and New World Arenaviruses

(2008) J. M. Rojek et al.   JOURNAL OF VIROLOGY